<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>qEEGsupport.com &#187; Brain Science</title>
	<atom:link href="http://qeegsupport.com/tag/brain-science/feed/" rel="self" type="application/rss+xml" />
	<link>http://qeegsupport.com</link>
	<description>Quantitative Electroencephalography (qEEG): Information &#38; Discussion</description>
	<lastBuildDate>Mon, 26 Apr 2010 22:44:31 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.4</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>How EEG can Show an Epileptogenic Process</title>
		<link>http://qeegsupport.com/how-eeg-can-show-an-epileptogenic-process/</link>
		<comments>http://qeegsupport.com/how-eeg-can-show-an-epileptogenic-process/#comments</comments>
		<pubDate>Mon, 26 Apr 2010 22:10:30 +0000</pubDate>
		<dc:creator>Jay Gunkelman</dc:creator>
				<category><![CDATA[Brain Science]]></category>
		<category><![CDATA[neurofeedback]]></category>
		<category><![CDATA[qEEG]]></category>
		<category><![CDATA[EEG]]></category>
		<category><![CDATA[EEG biofeedback]]></category>
		<category><![CDATA[epilepsy]]></category>
		<category><![CDATA[neurotherapy]]></category>

		<guid isPermaLink="false">http://qeegsupport.com/?p=562</guid>
		<description><![CDATA[This is the first of a few posts with a variety of ways  the EEG can show an epileptogenic process.  The morphology of the underlying  process are quite dramatically varied.
The two images below show the referential and sequential  montage display of an active right temporal-parietal spike and slow wave focus,  [...]]]></description>
			<content:encoded><![CDATA[<p>This is the first of a few posts with a variety of ways  the EEG can show an epileptogenic process.  The morphology of the underlying  process are quite dramatically varied.</p>
<p>The two images below show the referential and sequential  montage display of an active right temporal-parietal spike and slow wave focus,  seen in a child clinically diagnosed with an attachment disorder. There was no  history of convulsion, nor any  suspicion of the actual underlying pathophysiological basis for the behavioral  presentation.</p>
<p><span id="more-562"></span></p>
<p>The focus cortical area is normally involved in  comprehension of facial expression and body language, as well as the prosodic  (emotive) aspects of language.  Any disturbance in that cortical area’s function  generally has social contextual implications for behavior due to “prosodic  blindness”. (see: <em><span style="text-decoration: underline;">Van Bloem, L.  QEEG in  Children with Reactive Attachment Disorder, </span></em></p>
<p><em><span style="text-decoration: underline;">Journal of Neurotherapy, 4(4),  2001</span></em>.</p>
<p>The implications for treatment option with this  pathophysiological source for the behavioral presentation which could really  only be discovered through the EEG are enormous.  The use of an  anticonvulsant or an approach with  one of the proven efficacious applications of Neurofeedback in treating epilepsy  can be used to target the underlying cause, rather than trying to effect some  symptomatic control with antipsychotic or antidepressant medications so commonly  used in these situations of severe attachment disorder.  (see a review of SMR  applied to epilepsy by Dr. M. Barry Sterman, Professor Emeritus, UCLA, from 2000  in Clinical Electroencephalography’s special edition on Neurofeedback)</p>
<p>In these images the referential focus is seen associated  with the largest waveform, though in the sequential data the 180 degree phase  reversal points to the focus.</p>
<div class="wp-caption alignnone" style="width: 618px"><img title="Referential Montage Display" src="http://qeegsupport.com/wp-content/uploads/2010/referential.gif" alt="EEG &amp; Epilespy Referential Montage Display" width="608" height="394" /><p class="wp-caption-text">EEG &amp; Epilepsy - Referential Montage Display</p></div>
<div class="wp-caption alignleft" style="width: 618px"><img title="Sequential Montage Display" src="http://qeegsupport.com/wp-content/uploads/2010/sequential.gif" alt="EEG &amp; Epilepsy" width="608" height="396" /><p class="wp-caption-text">EEG &amp; Epilepsy - Sequential Montage Display</p></div>
]]></content:encoded>
			<wfw:commentRss>http://qeegsupport.com/how-eeg-can-show-an-epileptogenic-process/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Epilepsy and EEG</title>
		<link>http://qeegsupport.com/epilepsy-and-eeg/</link>
		<comments>http://qeegsupport.com/epilepsy-and-eeg/#comments</comments>
		<pubDate>Mon, 26 Apr 2010 18:08:27 +0000</pubDate>
		<dc:creator>Jay Gunkelman</dc:creator>
				<category><![CDATA[Brain Science]]></category>
		<category><![CDATA[neurofeedback]]></category>
		<category><![CDATA[qEEG]]></category>
		<category><![CDATA[EEG]]></category>
		<category><![CDATA[EEG biofeedback]]></category>
		<category><![CDATA[epilepsy]]></category>
		<category><![CDATA[patterns]]></category>
		<category><![CDATA[seizure]]></category>
		<category><![CDATA[temporal lobe epilepsy]]></category>

		<guid isPermaLink="false">http://qeegsupport.com/?p=556</guid>
		<description><![CDATA[Epilepsy and EEG have been inextricably  linked since the 1930s, when Frederick and Erna Gibbs discovered that epileptic  events were visible in the EEG.  The evolution of other medical imaging in the  1970s and 1980s provided a better way to localize tumors, and the clinical use  tapered off in areas other [...]]]></description>
			<content:encoded><![CDATA[<p>Epilepsy and EEG have been inextricably  linked since the 1930s, when Frederick and Erna Gibbs discovered that epileptic  events were visible in the EEG.  The evolution of other medical imaging in the  1970s and 1980s provided a better way to localize tumors, and the clinical use  tapered off in areas other than epilepsy and encephalopathies.  Even with the  multiplicity of other methods, the EEG remains the gold standard for  identification of epilepsy.</p>
<p>In modern neuroscience centers, the EEG is  still the tool of choice in evaluation of convulsive epilepsy, as well as some other  non-convulsive forms, such as staring  episodes seen in “absence epilepsy” typically as a 3/second spike and wave  dominant anteriorly, or temporal lobe epilepsy, which is seen as a “notched”  slow wave discharge fronto-temporally.<span id="more-556"></span></p>
<p>The EEG can now be processed through  algorithms, such as spike dipole localization software, to identify the “seizure  focus” cortically, or spectral averaging to look for changes in the underlying  EEG rhythmicity due to the disorder.</p>
<p>One of the difficulty with the two later  categories is that they are not always identified as forms of epilepsy, and thus  can be mis-diagnosed based on behavior alone as some other disorders, including  ADD/ADHD in absence epilepsy “spells”  where the attentional process is disturbed by the discharge taking segments of  time out of the cognitive streaming of perception, or from discharge in sensory  areas.  These segments being removed do not have any conscious awareness of the  event for the person experiencing the blips missing from their cognitive  process, and they will have trouble tracking on-going events, like driving or  listening to a speech or lecture.  Imagine missing a few here and there, to tens  of seconds from your awareness, and see if you don’t have “attentional  deficits”.</p>
<p>The other major areas of misdiagnosis are  of a “schizophrenic” or “psychotic” nature.  This occurs when the discharges are  frontal or temporal and disturbing local cortical function, and may be seen as a  range of presentations from hallucinations or emotional outbursts of rage, or  even “fits of laughter” in “Gelastic seizures”.   Temporal Lobe Epilepsy (TLE)  is a particularly difficult one to properly diagnose in the absence of the  EEG.</p>
<p>The importance of these missed-diagnoses  can be quite severe, with the use of medications to treat the symptoms often  being contra-indicated by the epilepsy.  One example of this is TLE that is  assumed to be psychosis, since antipsychotic medications lower the seizure  threshold, and make the person worse, which can then be responded to with more  antipsychotics, spiraling the person into a progressively worsened condition.   The use of stimulants in epilepsy is a controversial area, as the effect of  stimulants for inattention in known and treated epileptics may be acceptable,  though throwing a stimulant at an undiagnosed epileptic can have severe negative  consequences.</p>
<p>The real issue is that IF YOU DO NOT LOOK,  YOU WILL NOT SEE… and in epilepsy, looking requires the EEG, as the gold  standard.</p>
<p>In surgical approaches, the EEG is used to  identify whether there are multiple foci, which generally will preclude a good  outcome (you remove the brain tissue and the seizures do not  change).</p>
<p>I will post some images of the WIDE  variety of morphologic presentation that epilepsy can take, so that some  understanding of the task of the Electroencephalographer and Epileptologist can  be better appreciated by those who think it is  straight-forward.</p>
<p>Thanks for your attention to these obscure  issues.</p>
<p>Jay</p>
]]></content:encoded>
			<wfw:commentRss>http://qeegsupport.com/epilepsy-and-eeg/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>First Direct Evidence of Neuroplastic Changes Following Brainwave Training</title>
		<link>http://qeegsupport.com/first-direct-evidence-of-neuroplastic-changes-following-brainwave-training/</link>
		<comments>http://qeegsupport.com/first-direct-evidence-of-neuroplastic-changes-following-brainwave-training/#comments</comments>
		<pubDate>Tue, 16 Mar 2010 20:48:41 +0000</pubDate>
		<dc:creator>Jay Gunkelman</dc:creator>
				<category><![CDATA[ADHD / ADD]]></category>
		<category><![CDATA[Addiction]]></category>
		<category><![CDATA[Alzheimers/Dementia]]></category>
		<category><![CDATA[Brain Science]]></category>
		<category><![CDATA[Traumatic Brain Injury (TBI)]]></category>
		<category><![CDATA[neurofeedback]]></category>
		<category><![CDATA[qEEG in the media]]></category>
		<category><![CDATA[cognitive-behavioral treatment]]></category>
		<category><![CDATA[EEG]]></category>
		<category><![CDATA[EEG biofeedback]]></category>
		<category><![CDATA[neurotherapy]]></category>
		<category><![CDATA[Personalized Medicine]]></category>

		<guid isPermaLink="false">http://qeegsupport.com/?p=549</guid>
		<description><![CDATA[The scientific and academic press is now considering  Neurofeedback as one of the ways neural plasticity can be induced/enhanced.  The paper below shows the NF training changing the brain&#8217;s plasticity  measurably within a single feedback session.
This may not surprise  too many old-time NF practitioners, except that it is now being proven [...]]]></description>
			<content:encoded><![CDATA[<p>The scientific and academic press is now considering  Neurofeedback as one of the ways neural plasticity can be induced/enhanced.  The paper below shows the NF training changing the brain&#8217;s plasticity  measurably within a single feedback session.</p>
<p>This may not surprise  too many old-time NF practitioners, except that it is now being proven with  well done studies in the traditional neuroscience literature!  Neurofeedback  can induce changes in brain plasticity!</p>
<p>Jay</p>
<p><strong>First Direct Evidence of Neuroplastic Changes Following Brainwave Training</strong></p>
<p>ScienceDaily (Mar. 12, 2010) — Significant changes in brain plasticity have been observed following alpha brainwave training.</p>
<p>A pioneering collaboration between two laboratories from the University of London has provided the first evidence of neuroplastic changes occurring directly after natural brainwave training. Researchers from Goldsmiths and the Institute of Neurology have demonstrated that half an hour of voluntary control of brain rhythms is sufficient to induce a lasting shift in cortical excitability and intracortical function.</p>
<p>Remarkably, these after-effects are comparable in magnitude to those observed following interventions with artificial forms of brain stimulation involving magnetic or electrical pulses. The novel finding may have important implications for future non-pharmacological therapies of the brain and calls for a serious re-examination and stronger backing of research on neurofeedback, a technique which may be promising tool to modulate cerebral plasticity in a safe, painless, and natural way.</p>
<p>Continued at <a title="Science Daily" href="http://www.sciencedaily.com/releases/2010/03/100310114936.htm" target="_blank">http://www.sciencedaily.com/releases/2010/03/100310114936.htm</a></p>
]]></content:encoded>
			<wfw:commentRss>http://qeegsupport.com/first-direct-evidence-of-neuroplastic-changes-following-brainwave-training/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The Art of Aging: Limitless Potential of the Brain</title>
		<link>http://qeegsupport.com/the-art-of-aging-limitless-potential-of-the-brain/</link>
		<comments>http://qeegsupport.com/the-art-of-aging-limitless-potential-of-the-brain/#comments</comments>
		<pubDate>Fri, 19 Feb 2010 21:22:26 +0000</pubDate>
		<dc:creator>Brian Milstead</dc:creator>
				<category><![CDATA[Alzheimers/Dementia]]></category>
		<category><![CDATA[Brain Science]]></category>
		<category><![CDATA[Traumatic Brain Injury (TBI)]]></category>
		<category><![CDATA[qEEG]]></category>
		<category><![CDATA[qEEG in the media]]></category>
		<category><![CDATA[alzheimers]]></category>
		<category><![CDATA[brain injury]]></category>
		<category><![CDATA[brain mapping]]></category>
		<category><![CDATA[cognitive-behavioral treatment]]></category>
		<category><![CDATA[dementia]]></category>
		<category><![CDATA[neurotherapy]]></category>

		<guid isPermaLink="false">http://qeegsupport.com/?p=534</guid>
		<description><![CDATA[This is an excellent video talking about how seniors can help keep their brains young.
How can we live a fuller and healthier lifestyle as we get older? Perhaps keeping our body and brain engaged can help. That seems to be the case in Japan where the number of centegenarians is greater than 20,000. 
THE ART [...]]]></description>
			<content:encoded><![CDATA[<p>This is an excellent video talking about how seniors can help keep their brains young.</p>
<p>How can we live a fuller and healthier lifestyle as we get older? Perhaps keeping our body and brain engaged can help. That seems to be the case in Japan where the number of centegenarians is greater than 20,000. </p>
<p>THE ART OF AGING:THE LIMITLESS POTENTIAL OF THE BRAIN introduces a number of these &#8220;super-seniors&#8221; who lead healthy lives at nearly 100-years-old and, through them,searches for the &#8220;keys&#8221; to living a healthy and vital life regardless of age.</p>
<p><a href="http://qeegsupport.com/the-art-of-aging-limitless-potential-of-the-brain/"><em>Click here to view the embedded video.</em></a></p>
]]></content:encoded>
			<wfw:commentRss>http://qeegsupport.com/the-art-of-aging-limitless-potential-of-the-brain/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Three Sets of Data from the Same EEG</title>
		<link>http://qeegsupport.com/three-sets-of-data-from-the-same-eeg/</link>
		<comments>http://qeegsupport.com/three-sets-of-data-from-the-same-eeg/#comments</comments>
		<pubDate>Mon, 01 Feb 2010 18:22:25 +0000</pubDate>
		<dc:creator>Jay Gunkelman</dc:creator>
				<category><![CDATA[Brain Science]]></category>
		<category><![CDATA[qEEG]]></category>
		<category><![CDATA[brain mapping]]></category>
		<category><![CDATA[patterns]]></category>
		<category><![CDATA[technical issues]]></category>

		<guid isPermaLink="false">http://qeegsupport.com/?p=522</guid>
		<description><![CDATA[This is three sets of data from the same underlying EEG, all with varying coherence results, and with the weighted average showing the alpha hypercoherent pattern with better fidelity than any other for this data.
These results are from 300 seconds of  linked ear EEG data, note the dominant slower alpha peak frontally…. And the [...]]]></description>
			<content:encoded><![CDATA[<p>This is three sets of data from the same underlying EEG, all with varying coherence results, and with the weighted average showing the alpha hypercoherent pattern with better fidelity than any other for this data.<span id="more-522"></span></p>
<p><span style="font-family: Times New Roman; color: black; font-size: small;"><span style="font-size: 12pt; color: black;">These results are from 300 seconds of  linked ear EEG data, note the dominant slower alpha peak frontally…. And the raw  coherence values of that linked ear data. The raw EEG file sample is  also included, so you can see the  waveforms these values are being drawn from.</span></span></p>
<p><span style="font-family: Times New Roman; color: black; font-size: small;"><span style="font-size: 12pt; color: black;"></p>
<div class="wp-caption aligncenter" style="width: 522px"><img title="Linked Ears 1" src="http://qeegsupport.com/wp-content/uploads/2010/linkedears1.jpg" alt="Linked Ears" width="512" height="293" /><p class="wp-caption-text">Linked Ears</p></div>
<div class="wp-caption aligncenter" style="width: 528px"><img title="Raw Coherence Values of Linked Ear Data" src="http://qeegsupport.com/wp-content/uploads/2010/linkedears2.jpg" alt="Raw Coherence Values of Linked Ear Data" width="518" height="296" /><p class="wp-caption-text">Raw Coherence Values of Linked Ear Data</p></div>
<div class="wp-caption aligncenter" style="width: 548px"><img title="Raw EEG " src="http://qeegsupport.com/wp-content/uploads/2010/linkedears3.jpg" alt="Raw EEG" width="538" height="275" /><p class="wp-caption-text">Raw EEG</p></div>
<p></span></span></p>
<p>The same exact 300 seconds of EEG data,  reprocessed now with the weighted average montage.  Note the difference in  spectra, and waveform!!!  The temporal slower alpha is now seen as the source of  that slower alpha content.</p>
<p><strong><em><span style="text-decoration: underline;">The  alpha hypercoherence in the EEG is easily seen in this data, but not in the  linked ears.</span></em></strong></p>
<p>This shows that you need to find the EEG  montage that shows the actual EEG data for your case first, and THEN calculate  coherence.</p>
<div class="wp-caption aligncenter" style="width: 596px"><img title="Weighted Average Spectra" src="http://qeegsupport.com/wp-content/uploads/2010/weighted3.jpg" alt="Weighted Average Spectra" width="586" height="335" /><p class="wp-caption-text">Weighted Average Spectra</p></div>
<div class="wp-caption aligncenter" style="width: 558px"><img title="Weighted Average Waveform" src="http://qeegsupport.com/wp-content/uploads/2010/weighted2.jpg" alt="WEighted Average Waveform" width="548" height="314" /><p class="wp-caption-text">Weighted Average Waveform</p></div>
<div class="wp-caption aligncenter" style="width: 572px"><img title="Weighted Average Raw" src="http://qeegsupport.com/wp-content/uploads/2010/weighted1.jpg" alt="Weighted Average Raw" width="562" height="286" /><p class="wp-caption-text">Weighted Average Raw</p></div>
<p>The images below show the Spectral plot, coherence plot and raw EEGs. Just like the other montages did. The Cz coherences are so inflated with field effects they are at 0.8 across the full spectrum at some sites, obviously artifactually high.</p>
<div class="wp-caption aligncenter" style="width: 586px"><img title="Spectral Plot" src="http://qeegsupport.com/wp-content/uploads/2010/spectral.jpg" alt="Spectral Plot" width="576" height="311" /><p class="wp-caption-text">Spectral Plot</p></div>
<div class="wp-caption aligncenter" style="width: 595px"><img title="Coherence Plot" src="http://qeegsupport.com/wp-content/uploads/2010/coherence.jpg" alt="Coherence Plot" width="585" height="315" /><p class="wp-caption-text">Coherence Plot</p></div>
<div class="wp-caption aligncenter" style="width: 608px"><img title="Raw EEG" src="http://qeegsupport.com/wp-content/uploads/2010/raweeg.jpg" alt="Raw EEG" width="598" height="305" /><p class="wp-caption-text">Raw EEG</p></div>
]]></content:encoded>
			<wfw:commentRss>http://qeegsupport.com/three-sets-of-data-from-the-same-eeg/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>AAPB 41st Annual Meeting : Personalized Medicine in the Age of Technology: Psychophysiology &amp; Health</title>
		<link>http://qeegsupport.com/aapb-41st-annual-meeting-personalized-medicine-in-the-age-of-technology-psychophysiology-health/</link>
		<comments>http://qeegsupport.com/aapb-41st-annual-meeting-personalized-medicine-in-the-age-of-technology-psychophysiology-health/#comments</comments>
		<pubDate>Thu, 14 Jan 2010 17:46:40 +0000</pubDate>
		<dc:creator>Brian Milstead</dc:creator>
				<category><![CDATA[Brain Science]]></category>
		<category><![CDATA[Traumatic Brain Injury (TBI)]]></category>
		<category><![CDATA[neurofeedback]]></category>
		<category><![CDATA[qEEG]]></category>
		<category><![CDATA[qEEG in the media]]></category>
		<category><![CDATA[aapb]]></category>
		<category><![CDATA[brain injury]]></category>
		<category><![CDATA[Personalized Medicine]]></category>
		<category><![CDATA[ramachandran]]></category>
		<category><![CDATA[tbi]]></category>
		<category><![CDATA[traumatic brain injury]]></category>

		<guid isPermaLink="false">http://qeegsupport.com/?p=520</guid>
		<description><![CDATA[AAPB is traveling to San Diego, California for its 41st Annual Meeting. Mark your calendars for March 24-27, 2010 to attend this gathering of experts in biofeedback, neurofeedback, and applied psychophysiology. You won&#8217;t want to miss this educational event and the networking opportunities available!
We are honored to welcome several high-profile speakers, including:

Personalized Medicine in the [...]]]></description>
			<content:encoded><![CDATA[<p><a title="AAPB Website" href="http://aapb.org/" target="_blank">AAPB</a> is traveling to San Diego, California for its 41st Annual Meeting. Mark your calendars for March 24-27, 2010 to attend this gathering of experts in biofeedback, neurofeedback, and applied psychophysiology. You won&#8217;t want to miss this educational event and the networking opportunities available!</p>
<p>We are honored to welcome several high-profile speakers, including:</p>
<ul>
<li><strong><em>Personalized Medicine in the Age of Technology</em> <em>-</em></strong> <a title="Vilayanur S. Ramachandran MD, PhD Video Collection" href="http://qeegsupport.com/secrets-of-the-mind/" target="_blank">Vilayanur S. Ramachandran, MD, PhD</a>; Director of the Center for Brain and Cognition and Professor with the Psychology Department and Neurosciences Program at the University of California, San Diego, and Adjunct Professor of Biology at the Salk Institute</li>
</ul>
<ul>
<li> <strong>Regeneration and Stress at Work: Strategies for Improved Employee Health -</strong> Tores Theorell, MD, PhD; Professor Emeritus at the University of Stockholm, Sweden</li>
</ul>
<ul>
<li> <strong>An Overview of Mind Body Healing -</strong> C. Norman Shealy, MD, PhD; founder of the American Holistic Medical Association, and past president of the International Society for the Study of Subtle Energies and Energy Medicine</li>
</ul>
<ul>
<li> <strong>Neurotherapy in the Treatment of Traumatic Brain Injury: A Physiological Hypothesis</strong> &#8211; Paul Rapp, PhD; Professor in the Department of Military and Emergency Medicine at the Uniformed Services University of the Health Sciences</li>
</ul>
]]></content:encoded>
			<wfw:commentRss>http://qeegsupport.com/aapb-41st-annual-meeting-personalized-medicine-in-the-age-of-technology-psychophysiology-health/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>Thinking happy thoughts: MindRoom in the works for Canucks</title>
		<link>http://qeegsupport.com/thinking-happy-thoughts-mindroom-in-the-works-for-canucks/</link>
		<comments>http://qeegsupport.com/thinking-happy-thoughts-mindroom-in-the-works-for-canucks/#comments</comments>
		<pubDate>Sun, 03 Jan 2010 08:19:57 +0000</pubDate>
		<dc:creator>Brian Milstead</dc:creator>
				<category><![CDATA[Brain Science]]></category>
		<category><![CDATA[neurofeedback]]></category>
		<category><![CDATA[qEEG in the media]]></category>
		<category><![CDATA[cognitive-behavioral treatment]]></category>
		<category><![CDATA[mental game]]></category>
		<category><![CDATA[mind room]]></category>
		<category><![CDATA[peak performance]]></category>
		<category><![CDATA[thought technology]]></category>

		<guid isPermaLink="false">http://qeegsupport.com/?p=512</guid>
		<description><![CDATA[Thinking happy thoughts: MindRoom in the works for Canucks.
An excellent story regarding the use of Neurofeedback in sports.  The Mind Room utilizes the Thought Technology Procomp Infiniti equipment.
]]></description>
			<content:encoded><![CDATA[<p><a href="http://www.vancouversun.com/sports/ThinkinghappythoughtsMindRoomworksCanucks/2325997/story.html">Thinking happy thoughts: MindRoom in the works for Canucks</a>.</p>
<p>An excellent story regarding the use of Neurofeedback in sports.  The Mind Room utilizes the Thought Technology Procomp Infiniti equipment.</p>
]]></content:encoded>
			<wfw:commentRss>http://qeegsupport.com/thinking-happy-thoughts-mindroom-in-the-works-for-canucks/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>Drug exposure and EEG/qEEG findings</title>
		<link>http://qeegsupport.com/drug-exposure-and-eegqeeg-findings/</link>
		<comments>http://qeegsupport.com/drug-exposure-and-eegqeeg-findings/#comments</comments>
		<pubDate>Wed, 23 Dec 2009 05:53:34 +0000</pubDate>
		<dc:creator>Jay Gunkelman</dc:creator>
				<category><![CDATA[Addiction]]></category>
		<category><![CDATA[Brain Science]]></category>
		<category><![CDATA[qEEG]]></category>
		<category><![CDATA[EEG]]></category>
		<category><![CDATA[substance abuse disorder]]></category>

		<guid isPermaLink="false">http://qeegsupport.com/?p=487</guid>
		<description><![CDATA[A technical guide by Jay Gunkelman, QEEG-D
General comments:
There is a generally reciprocal effect between alpha and beta, as brain stem stimulation desynchronizes the alpha generators, beta is seen.  During states of under-arousal, this relationship is not seen, as when the subject is alerted, when both alpha and beta increase.
The point is that the arousal level [...]]]></description>
			<content:encoded><![CDATA[<p>A technical guide by Jay Gunkelman, QEEG-D</p>
<p><strong>General comments:</strong></p>
<p>There is a generally reciprocal effect between alpha and beta, as brain stem stimulation desynchronizes the alpha generators, beta is seen.  During states of under-arousal, this relationship is not seen, as when the subject is alerted, when both alpha and beta increase.</p>
<p>The point is that <em>the arousal level changes the EEG responses expected</em>, as when a stimulant is given to an under-aroused subject, increasing alpha. In a normally aroused subject, stimulants decrease alpha, and in an anxious (low voltage fast EEG variant) subject alpha will not be seen as changed by a stimulant.</p>
<p>Though there is a <em>response stereotype</em> for each medication, there are also individual responses, which vary. Mixtures of medications become too complex to evaluate each individual medication’s contribution, not to speak of <em>synergistic effects</em> not seen with any single medication, which may be seen in polytherapy.</p>
<p>The following pages represent a summary of many articles, papers, reviews and books on medications and the CNS function, and finally nearly 30 years of experience in clinical and research EEG. The difficulty in this area is the definitions of bands varies, the methods of analysis range from visual inspection of the raw EEG to quantitative measures, not all of which are clearly defined… and thus the need for a brief summary which puts this into a concise form for reference.<span id="more-487"></span></p>
<p>I will use the following definitions for the EEG bands. <em>Delta</em> is .5-3.5 Hz.; <em>theta</em> is 3.5-7 Hz, with slowing describing activity starting in the delta band, fading out in amplitude through the theta band. <em>Alpha</em> is 7-13 Hz, with “<em>high alpha</em>” being 11-15 or 16 Hz. <em>Beta is</em> from 13 Hz to the high frequency response of the system.</p>
<p>Due to the difficulty in visually detecting many of the changes reported, even small but significant changes can be missed. Don’t expect to “see” every change noted in each patient, or when using only visual inspection.</p>
<p><strong>Marijuana/ Hashish/ THC:</strong></p>
<p>There is increased frontal alpha, with increased frontal interhemispheric hypercoherence and phase synchrony.  These findings are reported in chronic exposures.</p>
<p>Effects on the evoked potentials have been noted as well.</p>
<p><strong>Lysergic acid diethylamide (LSD-25):</strong></p>
<p>The baseline EEG seems to determine the effect, with decreased alpha and increased beta from a normal background.  With slower EEGs, there is an increase in alpha and fast activity. The low voltage fast EEG shows little change in spectral profile with exposure.</p>
<p>The increase in <em>conditioned inhibition</em> seen with lower doses corresponds to the decrease in paroxysmal activity. The stimulant effects of this powerful drug may cause convulsions at higher doses, such as the early government studies. In these studies, <em>milligram</em> doses were supplanted for the <em>microgram</em> recommendations from Switzerland, where the LDS was produced.</p>
<p><strong> </strong></p>
<p><strong>PCP, Phencyclidine, or angel dust:</strong></p>
<p>There is a marked increase in slow activity, with paroxysmal activity and extreme voltages noted with increased dosage. Convulsions have been reported.</p>
<p><strong>Barbiturates:</strong></p>
<p>Rhythmic 18 to 26 Hz activity is noted, initially frontally, spreading with time to the entire cortex. With increased dose there is an increase in slowing, with further increases the faster activity is decreased and the slowing predominates, progressing to a decreased voltage and even a recoverable iso-electric pattern, in barbiturate coma.</p>
<p><strong>Morphine/Opiates/Heroin:</strong></p>
<p>Shortly following administration, there is increased alpha, with slowing of alpha during the euphoric high, with increased dose there is increased slowing, and like barbiturates the EEG may go iso-electric. There is an increase in REM sleep noted with opioids.</p>
<p><strong>Alcohol:</strong></p>
<p><em>Ethanol</em> at higher levels causes slowing to occur, with the depressant effect seen behaviorally.  In the low voltage fast type EEG (seen in anxious, nervous and in many chronic alcoholics and their family members), the initial alcohol exposure causes the sudden occurrence of alpha. With severe chronic alcoholism, there can be an abnormal pattern <em>of periodic lateralized epileptiform discharges (PLEDS)</em> seen with obtundation. This is not true underlying epilepsy, but rather disappears with the treatment of the alcoholism.</p>
<p><strong>Neuroleptics:</strong></p>
<p>“Tranquilizers” such as <em>chlorpromazine</em>, or it’s equivalent, increase the coherence of the EEG and decrease beta, however they increase temporal and frontal sharp morphologic theta transients. There is a reduced alpha blocking with sensory stimulation, likely corresponding to the memory disturbance reported with these medications.</p>
<p>In cases of <em>dopamine receptor hypersensitivity</em> (tardive dyskinesia) there are prolonged bursts of mixed fast/sharp transients and slowing. There is a potentiation of latent epileptiform activity, even with lower doses.</p>
<p><em>Thioridazine</em> also increases faster activity, accounting for its commonly reported antidepressant effects.</p>
<p><em>Clozapine, or Clozaril,</em> shows the typical neuroleptic pattern, though with an increase in epileptiform discharges and increasing possibility with duration of medication usage, reaching as high as 30% of patients with epileptogenic EEGs after 3 years of use.</p>
<p><strong> </strong></p>
<p><strong>Anxiolytics:</strong></p>
<p><em>Meprobamate</em> was the first anxiolytic, or anti-anxiety, medication. It decreases alpha and increases beta over 20 Hz, also slightly increasing theta, while not increasing epileptiform activity or paroxysms. The <em>benzodiazapines</em>, like <em>Valium or Ativan</em> also decrease alpha and increase the 20-30 Hz band, with a sinusoidal hyper-rhythmic spindling waveform. Paroxysmal and epileptiform discharges are reduced with these medications. The effect of decreasing neural has been used for its anti-epileptic qualities, especially in cases of <em>status epilepticus</em>, where Intravenous Valium has the apparently “comatose” patient sitting up wondering what has been happening.</p>
<p><strong>Hormones:</strong></p>
<p><em>Vasopressin</em>, usually in the form of DDAVP (desomopressin acetate), increases the high alpha band.  <em>Cyproterone acetate</em> is an anti-androgen with clinical effects on premenstrual complaints, though the qEEG effects predicted its strong anti-anxiety and mood elevating side effects. The decrease in frontal alpha and increased beta are noted.</p>
<p><strong>Antidepressants:</strong></p>
<p><strong> </strong><strong>Imipramine</strong><strong>:</strong></p>
<p>This drug produces an increase in slow activity, a decrease in alpha and high alpha, with an increase in the faster beta frequencies in the mid to upper 20 Hz range and up.</p>
<p><strong>Amitriptyline:</strong> This drug produces more slowing than imipramine, though the other effects are similar. This corresponds to an increased initial sedative effect and its use as a sleeping medication for sleep onset as well as the usual wakefulness effects of antidepressants. In epileptics, there are increases in paroxysmal discharges, which can be controlled normally with adjustments to the anti-epileptic medications.</p>
<p><strong>Ipronazid:</strong> This drug produces a slight increase in slower activity, though it produces a marked increase in faster activity. Paradoxically, this antidepressant does not produce an increase epileptiform profile or promote convulsions, even with this beta increase.</p>
<p><strong>MAO Inhibitors:</strong> These medications have a wider variation of response than the other antidepressants. <em>Isocarboxazide</em> increases 30-20 Hz and decreases slower and higher frequencies, similar to a stimulant profile. <em>Nialamide and Tranylcypromine produce</em> a more typical profile, though with more variability.</p>
<p><strong>SSRIs:</strong> These more modern antidepressants, such as Prozac, Paxil and Zoloft have fewer changes in the slow activity (associated with less viscero/autonomic side-effect), with a mild fronto-central beta increase in the range of 18-25 Hz and a decrease in alpha anteriorly.</p>
<p><strong>Stimulants:</strong></p>
<p>Stimulants increase the activity in the RAS, with the Raphe nucleus releasing norepinephrine, decreasing the polarization in the reticular nucleus of the thalamus and thus increasing the “clocking” or peak frequency of the rhythmic alpha activity and increasing faster activity.</p>
<p><strong>Amphetamines:</strong> Both <em>dextro and methamphetamines</em> like <em>Dextrostat or Adderal</em> are similar in effect, with decreased slower activity and increased beta from 12-26 Hz. There is a paradoxical increase in alpha noted in the CEEG work of Itil (Itil et al., 1980). This is likely from the increased activation effect mentioned in the opening section.</p>
<p><strong>Methylphenidate:</strong> <em>Ritalin</em> produces a decrease in delta and theta, with a more pronounced posterior alpha increase and an increase in low beta, with effects delayed up to 6 hours, compared to the rapid effects of the amphetamines.</p>
<p><strong>Caffeine:</strong> This moderate stimulant has a moderate length of effect, but has surprisingly little research on its EEG effect. A fairly current study of its withdrawal effects (Clinical EEG, Vol. 26 No.3, July 1995) shows an alpha increase frontally, with suppression following resumption. The study also shows theta increases with withdrawal, maximal the second day, resolving with resumption. The degree of change in both frequencies corresponds well to the subjective withdrawal severity.</p>
<p><strong>Nicotine:</strong> This drug has similar effects to caffeine, including the withdrawal study (Itil et al., 1971).</p>
<p><strong>Cocaine:</strong> The effects of cocaine differ from the amphetamines in that cocaine decreases <em>synaptic reuptake</em>, and amphetamines increase the release of the neurotransmitters in the <em>dopamine/norepinephrine</em> systems in the brain. With lower to moderate doses, there is increased alpha and beta. With increased doses there is a <em>desynchronization</em> of the EEG and faster activity predominates.</p>
<p>The alpha increase frontally is seen during the euphoric phase of the subjective report. Cocaine is a well-known <em>epileptic potentiator</em>. Chronic abuse causes a “burned out” dopamine system, with delta decreases and slower alpha noted with little improvement even one year later</p>
<p><strong> </strong></p>
<p><strong> </strong></p>
<p><strong>Antimanics:</strong></p>
<p><em>Lithium carbonate</em> is used extensively to treat bipolar depression, reducing the manic behavior and being prophylactic to depressive recurrences and further mania. The EEG shows an increase in theta, mild decrease in alpha as well as increased faster activity, with a strong potentiation of latent epileptiform activity. This mimics the tricyclic anti-depressant profile, though with slower slows and more fast activity.</p>
<p>Overdoses produce a marked slowing of the EEG, with <em>triphasic</em> discharges reported, likely associated with the liver toxicity and the associated metabolic disturbances, similar to the findings in <em>hepatic encephalopathies</em>. These slower findings may be noted many weeks following discharge from the hospital. Slowing of alpha (rhythmic background that responds to eye opening) down to 4 and 5 Hz two weeks after discharge from hospitalization, with normal 9 Hz alpha in the child returning only after many months is reported in a case study (NeuroNet Neuroscience Centers, 1999).</p>
<p><strong>Tuburculostatics:</strong></p>
<p>INH, <em>Isonicotinic acid hydrazide</em>, is an irritant to the CNS. Large doses can hypersensitize the CNS. The EEG shows bursts of paroxysmal activity with photic stimulation.</p>
<p><strong>Methanol:</strong></p>
<p>The EEG shows marked slowing, which correlates with the extent of <em>acidosis</em> more than the blood levels of methanol. This has been shown to be quite <em>neuro-toxic</em>, with optic nerve blindness noted commonly in chronic abuse/exposure.</p>
<p><strong>Solvents:</strong></p>
<p>The EEG show slowing, though the etiology remains uncertain, it is not without possibilities<em>. Polyneuropathy, dendritic degeneration and demyelination</em> have been seen in industrial exposures, any and/or all of which can cause slowing.</p>
<p><strong>Mercury:</strong></p>
<p>With initial exposure to this neurotoxin (and many other heavy metals) there is an increase of faster activity, though with increased concentrations there is an increase in fast and slow activity, with eventual paroxysmal activity of an epileptiform nature.</p>
<p><strong>Organo-phosphates:</strong></p>
<p>The insecticides are known to form <em>peripheral neuropathies</em>, though also have central actions. The EEG shows slowing and paroxysmal bursts, though in coma there is a paradoxical spindling fast activity.</p>
<p><strong>Chlorinated hydrocarbons:</strong></p>
<p>Also insecticidal, these chemical compounds are fat soluble, stored and accumulating to a toxic level they are known to cause convulsions. Neurologically, there are bi-temporal sharp discharges and anterior slowing, rarely are spikes noted, with or without convulsions.</p>
<p><strong>Lead, organic:</strong></p>
<p>Cerebrotoxic effects are strong, with IQ points dropped significantly even with trace measurable exposure. Dementia progresses with increased exposure, with eventual convulsions. The EEG shows diffuse slowing in sub-acute exposure, with increased exposure leading to paroxysmal discharges. Inorganic lead has weak cerebrotoxicity.</p>
<p><strong>Aluminum:</strong></p>
<p>Commonly seen in <em>dialysis encephalopathies</em>, with <em>myoclonic</em> activity seen behaviorally. Though not well documented, the EEG shows slowing with excessive fast activity, in my experience.  At autopsy, the aluminum is found concentrated anteriorly.</p>
<p>Provided courtesy of Jay Gunkelman, QEEG-Diplomate, Q-Pro Worldwide</p>
<h1>Epilepsia</h1>
<p>Volume 43 Issue 5 Page 482 &#8211; May 2002</p>
<p><strong>To cite this article:</strong> Martin C Salinsky, Lawrence M Binder, Barry S Oken, Daniel Storzbach, Carey R Aron, Carl B Dodrill (2002)<br />
Effects of Gabapentin and Carbamazepine on the EEG and Cognition in Healthy Volunteers<br />
Epilepsia 43 (5), 482–490.<br />
doi:10.1046/j.1528-1157.2002.22501.x</p>
<p>The results demonstrate that prolonged treatment with either CBZ or GBP can have significant effects on quantitative measures derived from EEG background rhythms. Both AEDs slowed the posteriorly dominant (alpha) EEG rhythm and median EEG frequency, and increased the percentage of theta and delta power. Overall, CBZ produced significantly greater slowing than did GBP. The observed test–retest changes are not simply shifts in group mean over time, but include many individuals (10 of 11 CBZ subjects, and six of 12 GBP subjects) whose test–retest change exceeded the 95% CI based on untreated healthy controls. Long-term AED treatment also affected several objective and most subjective measures of cognition and mood as compared with test–retest normative data obtained from untreated controls.</p>
]]></content:encoded>
			<wfw:commentRss>http://qeegsupport.com/drug-exposure-and-eegqeeg-findings/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Neurofeedback Demonstrated on &#8220;The Doctors&#8221;</title>
		<link>http://qeegsupport.com/neurofeedback-demonstrated-on-the-doctors/</link>
		<comments>http://qeegsupport.com/neurofeedback-demonstrated-on-the-doctors/#comments</comments>
		<pubDate>Sat, 05 Dec 2009 20:32:29 +0000</pubDate>
		<dc:creator>Brian Milstead</dc:creator>
				<category><![CDATA[ADHD / ADD]]></category>
		<category><![CDATA[Brain Science]]></category>
		<category><![CDATA[neurofeedback]]></category>
		<category><![CDATA[qEEG in the media]]></category>
		<category><![CDATA[add]]></category>
		<category><![CDATA[ADHD]]></category>
		<category><![CDATA[brain mapping]]></category>
		<category><![CDATA[neurotherapy]]></category>
		<category><![CDATA[Personalized Medicine]]></category>

		<guid isPermaLink="false">http://qeegsupport.com/?p=410</guid>
		<description><![CDATA[On this episode of the Doctors Dr Michael Linden helps &#8220;Noah&#8221; with his ADD. Part 1 of this story give a bit of information about what Noahs parents have been dealing with and the struggle they face with deciding whether or not to medicate their young child.

In Part 2 you see how Noah parents learn [...]]]></description>
			<content:encoded><![CDATA[<p>On this episode of the <a href="http://www.thedoctorstv.com/">Doctors</a> Dr Michael Linden helps &#8220;Noah&#8221; with his ADD. Part 1 of this story give a bit of information about what Noahs parents have been dealing with and the struggle they face with deciding whether or not to medicate their young child.</p>
<p><object width="410" height="341" data="http://www.veoh.com/static/swf/webplayer/WebPlayer.swf?version=AFrontend.5.4.7.1002&amp;permalinkId=v19450142hrqWR2PH&amp;player=videodetailsembedded&amp;videoAutoPlay=0&amp;id=19297880" type="application/x-shockwave-flash"><param name="id" value="veohFlashPlayer" /><param name="name" value="veohFlashPlayer" /><param name="allowFullScreen" value="true" /><param name="allowscriptaccess" value="always" /><param name="src" value="http://www.veoh.com/static/swf/webplayer/WebPlayer.swf?version=AFrontend.5.4.7.1002&amp;permalinkId=v19450142hrqWR2PH&amp;player=videodetailsembedded&amp;videoAutoPlay=0&amp;id=19297880" /><param name="allowfullscreen" value="true" /></object></p>
<p>In Part 2 you see how Noah parents learn there are alternatives to Ritalin and other drugs that may be given to their child. Learn about how Neurofeedback and EEG Brain Mapping may be able to help without the use of dangerous pharmaceutical drugs.</p>
<p><object width="410" height="341" data="http://www.veoh.com/static/swf/webplayer/WebPlayer.swf?version=AFrontend.5.4.7.1002&amp;permalinkId=v194507915CcWYRkJ&amp;player=videodetailsembedded&amp;videoAutoPlay=0&amp;id=19297880" type="application/x-shockwave-flash"><param name="id" value="veohFlashPlayer" /><param name="name" value="veohFlashPlayer" /><param name="allowFullScreen" value="true" /><param name="allowscriptaccess" value="always" /><param name="src" value="http://www.veoh.com/static/swf/webplayer/WebPlayer.swf?version=AFrontend.5.4.7.1002&amp;permalinkId=v194507915CcWYRkJ&amp;player=videodetailsembedded&amp;videoAutoPlay=0&amp;id=19297880" /><param name="allowfullscreen" value="true" /></object></p>
<p>Dr. Linden is a Clinical Psychologist and Nationally Certified in Neurofeedback and Biofeedback.  He is the director of <a title="Attening Learing Center website" href="http://mpccares.com/add.htm" target="_blank">The Attention Learning Center</a>, which has offices located in San Juan Capistrano, Irvine and Carlsbad, California.</p>
<p>Dr. Linden is a regular contributor to the Journal of Neurotherapy and has been a speaker in many seminars and conferences related to ADD/ADHD and neurotherapy. </p>
]]></content:encoded>
			<wfw:commentRss>http://qeegsupport.com/neurofeedback-demonstrated-on-the-doctors/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Cerebotix Brainwave Control of Remote Objects</title>
		<link>http://qeegsupport.com/cerebotix-brainwave-control-of-remote-objects/</link>
		<comments>http://qeegsupport.com/cerebotix-brainwave-control-of-remote-objects/#comments</comments>
		<pubDate>Sat, 05 Dec 2009 20:25:55 +0000</pubDate>
		<dc:creator>Brian Milstead</dc:creator>
				<category><![CDATA[Brain Science]]></category>
		<category><![CDATA[neurofeedback]]></category>
		<category><![CDATA[bci]]></category>
		<category><![CDATA[brain controlled]]></category>
		<category><![CDATA[brain controlled interface]]></category>
		<category><![CDATA[brain wave]]></category>
		<category><![CDATA[cerebotix]]></category>
		<category><![CDATA[EEG]]></category>

		<guid isPermaLink="false">http://qeegsupport.com/?p=407</guid>
		<description><![CDATA[John Lemay  and George Green Phd of Cerebotix introduced the world to their brainwave controlled blimp at the AAPB 2009 meeting in New Mexico.
Part 1

Part 2

Dr. George H. Green and John LeMay, MFT, have been collaborating in the area of brainwave biofeedback for several years. About a year and a half ago Cerebotix focused [...]]]></description>
			<content:encoded><![CDATA[<p>John Lemay  and George Green Phd of <a title="Cerebotix - Brain Wave Controlled Remote Devices" href="http://www.cerebotix.com" target="_blank">Cerebotix </a>introduced the world to their brainwave controlled blimp at the <a title="Association for Applied Psychophysiology &amp; Biofeedback" href="http://www.aapb.org" target="_blank">AAPB</a> 2009 meeting in New Mexico.</p>
<p><strong>Part 1</strong><br />
<object id="VideoPlayback" classid="clsid:d27cdb6e-ae6d-11cf-96b8-444553540000" width="400" height="350" codebase="http://download.macromedia.com/pub/shockwave/cabs/flash/swflash.cab#version=6,0,40,0"><param name="src" value="http://video.google.com/googleplayer.swf?docid=1599737110315237949&amp;hl=en&amp;fs=true" /><param name="allowfullscreen" value="true" /><embed id="VideoPlayback" type="application/x-shockwave-flash" width="400" height="350" src="http://video.google.com/googleplayer.swf?docid=1599737110315237949&amp;hl=en&amp;fs=true" allowfullscreen="true"></embed></object></p>
<p><strong>Part 2</strong><br />
<object id="VideoPlayback" classid="clsid:d27cdb6e-ae6d-11cf-96b8-444553540000" width="400" height="350" codebase="http://download.macromedia.com/pub/shockwave/cabs/flash/swflash.cab#version=6,0,40,0"><param name="src" value="http://video.google.com/googleplayer.swf?docid=8759178430847307698&amp;hl=en&amp;fs=true" /><param name="allowfullscreen" value="true" /><embed id="VideoPlayback" type="application/x-shockwave-flash" width="400" height="350" src="http://video.google.com/googleplayer.swf?docid=8759178430847307698&amp;hl=en&amp;fs=true" allowfullscreen="true"></embed></object></p>
<p><span id="more-407"></span>Dr. George H. Green and John LeMay, MFT, have been collaborating in the area of brainwave biofeedback for several years. About a year and a half ago Cerebotix focused on using the brainwaves monitored in biofeedback to move a remote object. After hundreds of hours of development, initial test subjects were able to successfully loft a remote controlled device (BCI &#8211; Brain Controlled Interface) in the Cerebotix corporate office. Since that time, countless refinements have been made, and the initial clinical results have been excellent.</p>
<p>In order to control a remote object, brainwaves are measured through five electrodes placed on the head. The resulting brainwave impulses are sent to a computer where they are processed through proprietary Cerebotix algorithms into three live data streams. These data streams are converted into radio frequency signals that are then transmitted to a wireless receiver mounted on a helium-filled Mylar balloon that has been ballasted to be slightly heavier than the surrounding air. As the person’s brainwaves become increasingly organized, the Remote Controlled Object (RCO) will develop enough power to activate a propeller, ascend and start to fly. The device is entirely under the control of the individual’s brainwaves. There are no additional controls in place whatsoever. The RCO is lifting off and flying literally 100% under brain control. This is the first time in history that brain waves have been used successfully to move remote objects.</p>
]]></content:encoded>
			<wfw:commentRss>http://qeegsupport.com/cerebotix-brainwave-control-of-remote-objects/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>